an Aussie bio-tech develops medicine for a disease
the new medicine is a huge improvement for certain kinds but a minority of the disease
the USA FDA makes problems for the Aussie bio-tech because Big Pharma does not want the Aussie bio-tech to have access to the entire market for the disease
Big Pharma only want the Aussie bio-tech to have limited access, to the minority of the market where is is most needed
the USA FDA make problems in the service of Big Pharma and Big Pharma then take over the Aussie biotech for a small proportion of its value
CXS Price at posting:
0.0¢ Sentiment: LT Sell Disclosure: Not Held
